biostudies-literatureUnknown2(3)Yamaji K<h4>Background</h4>Diabetes is a well-known risk factor for adverse outcomes after coronary revascularization.<h4>Objectives</h4>This study sought to determine high-risk subgroups in whom the excess risks of diabetes relative to nondiabetes are particularly prominent and thus may benefit from more aggressive interventions.<h4>Methods</h4>The study population consisted of 39,427 patients (diabetes: n = 15,561; nondiabetes: n = 23,866) who underwent first percutaneous coronary intervention (n = 33,144) or coronary artery bypass graft (n = 6,283) in the pooled CREDO-Kyoto PCI/CABG (Coronary Revascularization Demonstrating Outcome Study in Kyoto Percutaneous Coronary Intervention/Coronary Artery Bypass Graft) registry. The primary outcome measure was major adverse cardiovascular and cerebral eJACC. Asia294-308https://www.ebi.ac.uk/biostudies/studies/S-EPMC9675601biostudies-literatureModifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.PMC9675601Eizawa HCREDO-Kyoto PCI/CABG Registry InvestigatorsMitsuoka HNishiwaki NOgawa HTabata TTokushige AEsaki JOnoe MTatami RWatanabe HMatsuda MMatsuda KUchida YTezuka SYamanaka KYamazaki IKaburagi SKawanami MIwakura AKita TYamazaki KTakahashi AYamazaki FYamada MTakizawa ATaniguchi RMorioka KShinoda EToyofuku MMinatoya KKato ETYoshikawa YKaneda KFurukawa YArimura SOgawa TUegaito TDomei TSasae HDoi OKimura TKonishi TKuwahara TNohara RTsuda MNara MTambara KSato YYaku HMatoba YHorie MKitagawa KHara HNatsuaki MTsumori MMiura ATanaka KTanaka MTakumi TNishizawa JIshii KYamaji KNakano KFuki MTsuneyoshi HMabuchi HKadota KMiyamoto SNakano AYamashita YKunihiko NNobuyoshi MHamasaki SKihara YKinoshita YOkamoto NYoshida YMorimoto TFujino YLee JDKoyama TShirotani MEhara NMizoguchi TSugamura KTakinami EAkira YKomiya TSugiyama SNishikawa RMiki SOhno NDoyama KAota MHibi CHayano MShiomi HAoyama TYoshimoto MMatsumura-Nakano YMiki IYamamoto KSakurai TNakajima HTada TSakamoto HIshida KYamamoto HYasumoto HYamamoto TTakeji YImada KTakeuchi YIwabuchi MTazaki JNakatsuma KIkeda TMarui AMitsudo KSakai HHanyu MTada EAbe MSuwa SNakajima TYamamoto YTerai YAraki MSakata RKanemitsu NNasu MTakashima HInada TShimamoto MKato HTakatsu YTei CMatsushita TNakayama SOotani SKato MTamura NSaeki ATakahashi MYamamoto ETamura TMurakami TKato ESoga YKambara HKato YYamauchi MImoto YOnodera TKataoka KTakeda TAndo KKato RFujiwara HSuyama TSoga KKoshiji TKitamura MMinematsu SInoko MFujiwara KRyuzo NOkada YMoriyama SKawasuji MHattori RUzui HNishida SHanazawa MSachiko MNakagawa YKotoura HfalseModifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.<h4>Background</h4>Diabetes is a well-known risk factor for adverse outcomes after coronary revascularization.<h4>Objectives</h4>This study sought to determine high-risk subgroups in whom the excess risks of diabetes relative to nondiabetes are particularly prominent and thus may benefit from more aggressive interventions.<h4>Methods</h4>The study population consisted of 39,427 patients (diabetes: n = 15,561; nondiabetes: n = 23,866) who underwent first percutaneous coronary intervention (n = 33,144) or coronary artery bypass graft (n = 6,283) in the pooled CREDO-Kyoto PCI/CABG (Coronary Revascularization Demonstrating Outcome Study in Kyoto Percutaneous Coronary Intervention/Coronary Artery Bypass Graft) registry. The primary outcome measure was major adverse cardiovascular and cerebral e2022-01-01T00:00:00Z2022 Jun2025-04-18T14:58:42.642Z2025-04-07T01:23:34.41ZS-EPMC96756013641187610.1016/j.jacasi.2021.12.012